BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27

• Nicox Highlights Positive NCX 470 Phase 3 Data Confirming Therapeutic Profile at the 2026 American Glaucoma Society Annual Meeting

  February 24, 2026

   · 

  5 min read
• Press Releases

  Epredia and Mindpeak Announce EU Distribution Agreement for AI-Powered Image Recognition in Cancer Diagnostics

  February 24, 2026

   · 

  4 min read
• Press Releases

  Centauri Therapeutics Extends Series A to £30M With £6M Investment From AMR Action Fund to Support Progression of Lead Clinical Candidate

  February 24, 2026

   · 

  3 min read
• Press Releases

  ASTRA Therapeutics appoints Industry Leader Fabian Kausche as Chairman of the Board of Directors

  February 24, 2026

   · 

  4 min read
• Press Releases

  Sciwind Biosciences Partners with Pfizer China to Commercialize its Biased GLP-1 in China

  February 24, 2026

   · 

  3 min read
• Press Releases

  Greenwich LifeSciences Announces Acceptance of Two Abstracts at AACR Annual Meeting 2026

  February 24, 2026

   · 

  7 min read
• Press Releases

  Amphastar Announces FDA Approval for Ipratropium Bromide HFA

  February 24, 2026

   · 

  5 min read
• Press Releases

  Biodesix to Participate in Upcoming March 2026 Investor Conferences

  February 24, 2026

   · 

  1 min read
• Press Releases

  Successful Readout of Prospective Phase 2 SINERGY Trial Supports SignateraTM MRD-Guided Treatment in Head and Neck Cancer

  February 24, 2026

   · 

  4 min read
• Press Releases

  Palvella Therapeutics Announces Positive Topline Results from Phase 3 SELVA Clinical Study of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) in Microcystic Lymphatic Malformations

  February 24, 2026

   · 

  14 min read